Aspirin and Vascepa can generally be taken together, but it is important to consult with a healthcare professional before taking any new medication or combination of medications [2]. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain and reduce inflammation [1]. Vascepa, on the other hand, is a prescription medication used to reduce the risk of cardiovascular events in certain adult patient groups [3].
According to Drugs.com, there are no known interactions between aspirin and Vascepa [2]. However, it is important to note that both medications can increase the risk of bleeding. Aspirin can interfere with blood clotting, while Vascepa can increase bleeding time. Therefore, it is important to use caution when taking these medications together, especially if you are already taking other medications that can increase the risk of bleeding [2].
The FDA has approved the use of Vascepa to reduce the risk of cardiovascular events in certain adult patient groups [3]. It is important to note that Vascepa is not recommended for use in patients with a known hypersensitivity to the drug or any of its components. Additionally, Vascepa should not be used as a substitute for statins or other lipid-lowering drugs in patients with hypertriglyceridemia [3].
In summary, aspirin and Vascepa can generally be taken together, but it is important to consult with a healthcare professional before taking any new medication or combination of medications. While there are no known interactions between aspirin and Vascepa, both medications can increase the risk of bleeding. It is also important to note that Vascepa is only recommended for use in certain adult patient groups and should not be used as a substitute for other lipid-lowering drugs in patients with hypertriglyceridemia [2][3].
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/ASPIRIN
[2] https://www.drugs.com/drug-interactions/aspirin-with-vascepa-243-0-3407-15790.html
[3] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups